First-line (1L) zolbetuximab plus chemotherapy in patients (pts) with claudin 18.2 (CLDN18.2) +, HER2-, locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma: A pooled final analysis of SPOTLIGHT plus GLOW

被引：0

作者：

Kang, Y-K. ^{[1
]}

Shah, M. A. ^{[2
]}

Shitara, K. ^{[3
]}

Ajani, J. A. ^{[4
]}

Lordick, F. ^{[5
]}

Van Cutsem, E. ^{[6
]}

Ilson, D. H. ^{[7
]}

Klempner, S. J. ^{[8
]}

Yamaguchi, K. ^{[9
]}

Nakajima, T. ^{[10
]}

Cao, Y. J. ^{[11
]}

Li, R. ^{[12
]}

Moran, D. ^{[11
]}

Pophale, R. R. ^{[13
]}

Ranganath, R. ^{[13
]}

Xu, R-H. ^{[14
]}

机构：

[1] Univ Ulsan, Coll Med, Asan Med Ctr, Oncol Dept, Seoul, South Korea

[2] Weill Cornell Med Coll, Med Oncol & Hematol Dept, New York, NY USA

[3] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan

[4] Univ Texas MD Anderson Canc Ctr, GI Med Oncol, Houston, TX USA

[5] Univ Krebszentrum Leipzig, Univ Klinikum Leipzig, Med Dept, Leipzig, Germany

[6] UZ Leuven, Univ Hosp Leuven, Digest Oncol Dept, Campus Gasthuisberg, Leuven, Belgium

[7] Mem Sloan Kettering Evelyn H Lauder Breast Ctr, Dept Med, New York, NY USA

[8] MGH Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA USA

[9] Canc Inst Hosp JFCR, Gastroenterol Chemotherapy Dept, Koto Ku, Tokyo, Japan

[10] Astellas Pharma Global Dev, Med Dept, Northbrook, IL USA

[11] Astellas Pharma Global Dev Inc, Data Sci, Northbrook, IL USA

[12] Astellas Pharma Global Dev, Data Sci, Northbrook, IL USA

[13] Astellas Pharma Global Dev Inc, Med Affairs Dept, Northbrook, IL USA

[14] Sun Yat Sen Univ Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China

来源：

关键词：

D O I：

10.1016/j.annonc.2024.08.1504

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1438P

引用

页码：S895 / S895

页数：1